Pharmacology, Toxicology and Pharmaceutical Science
Histone Deacetylase Inhibitor
100%
Lactam
66%
Catenin
49%
Malignant Neoplasm
46%
Histone Deacetylase
45%
Neoplasm
37%
Mouse
36%
Hydroxamic Acid
28%
Apoptosis
28%
Quaternary Ammonium Derivative
27%
Biological Product
26%
Protein
26%
Phosphotransferase
24%
Pharmacokinetics
23%
Benzothiazole
22%
Enzyme
22%
Drug
21%
Rat
21%
Colorectal Cancer
20%
IC50
20%
Coenzyme Q - Cytochrome C Reductase
18%
Binding Protein
18%
Tumor Necrosis Factor Alpha Converting Enzyme Inhibitor
18%
Leucine Transfer RNA Ligase
17%
Acute Myeloid Leukemia
17%
Western Blot
16%
Dipeptidyl Carboxypeptidase
16%
I Kappa B Kinase Inhibitor
15%
Coumarin
15%
Parkinson Disease
15%
Nitric Oxide
14%
Cell Cycle
14%
Breast Cancer
14%
CD135 Antigen
13%
Monoamine Oxidase B Inhibitor
13%
Antiinfective Agent
13%
Anticarcinogen
13%
Wound Healing
13%
Sulfone
12%
Leukemia
12%
Bioavailability
11%
Quantitative Structure-Activity Relationship
11%
Carbon
11%
Boron 10
11%
Transcription Factor AP 1
10%
Anti-Inflammatory Drug
10%
Acid
9%
Lung Cancer
9%
Vorinostat
9%
Structure Activity Relationship
9%
Biochemistry, Genetics and Molecular Biology
Apoptosis
74%
Catenin
69%
Cancer Cell
47%
Protein
42%
Transfer RNA
41%
Small Molecule
35%
Kinase
31%
Electric Potential
27%
Regulatory Mechanism
25%
Histone Deacetylase
25%
Growth
25%
Development
25%
RUNX3
22%
KRAS
21%
Upregulation
21%
Mutation
21%
Stem Cell
19%
Peptide
18%
Phosphorylation
17%
Mammalian Target of Rapamycin Complex 1
17%
Leucine
17%
Histone
16%
Amyloid
16%
Binding Site
14%
Extract
13%
Epidermal Growth Factor Receptor
13%
Glycogen Synthase Kinase 3
13%
Signal Transduction
13%
Degradation
13%
Growth Inhibition
12%
Promoter Region
12%
Mouse
12%
Amino Acids
12%
Nested Gene
12%
Lysozyme
12%
RNA
12%
Binding Protein
11%
P53
11%
Mutant
11%
In Vitro Study
11%
Synthesis
11%
Cytochrome
10%
Cell Viability
10%
N-Terminus
10%
Cross-Link
10%
Tumor Necrosis Factor
10%
Transcription
9%
Sulfone
9%
HDAC6
9%
Reductase
9%
Medicine and Dentistry
Cells
55%
Programmed Cell Death
49%
Cancer Cell
44%
Catenin
39%
Quaternary Ammonium Derivative
27%
Cytokine Induced Killer Cell
27%
Assay
26%
Therapeutic Procedure
24%
Differentiation
21%
In Vitro
20%
Combination Therapy
20%
Upregulation
18%
Gene
18%
Lung Cancer
18%
Patient
17%
Anticarcinogen
16%
Indirubin
15%
Protein
15%
Growth
15%
Malignant Neoplasm
15%
Prostate Cancer
13%
Ras
13%
Antineoplastic Activity
13%
Growth Inhibition
12%
Pancreas Cancer
12%
Oxime
11%
Biological Activity
11%
Cancer Immunotherapy
11%
Phospholipase D
11%
Deuterium
10%
Neoplasm
10%
Gemcitabine
9%
Histone Deacetylase Inhibitor
9%
Evaluation Study
9%
Biological Product
9%
Coenzyme Q - Cytochrome C Reductase
9%
Protein Binding
9%
Epiphyseal Plate
9%
Magnolia
9%
Interleukin 8
9%
Histone Modification
9%
Reactive Oxygen Species
9%
Pendrin
9%
Transcription Factor AP 1
9%
Epidermal Growth Factor Receptor
9%
Stem Cell
9%
Beige Adipocyte
9%
Nicotinate Phosphoribosyltransferase
9%
Nicotinamide Phosphoribosyltransferase
9%
Prostaglandin D2
9%
